Abvc Biopharma, Inc. (ABVC): Operating Income
-$7.15M
Year ended 2025-12-31
-$6.52M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$7.15M | n/m | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | -$4.71M | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$6.77M | n/c | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$15.11M | n/m | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | -$11.71M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$8.51M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$3.46M | n/m | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | -$2.78M | n/c | 2020-05-15, From 2018-01-01 |
| 2017-12-31 | -$4.14M | n/a | 2019-04-15, From 2017-01-01 |
| No annual figure between 2016-09-30 and 2017-12-31. | |||
| 2016-09-30 | -$11.00M | n/a | 2018-01-16, From 2015-10-01 |
| No annual figure between 2013-09-30 and 2016-09-30. | |||
| 2013-09-30 | -$177.3K | n/m | 2015-04-16, From 2012-10-01 |
| 2012-09-30 | -$1.14M | n/m | 2015-04-16, From 2011-10-01 |
| 2011-09-30 | -$1.89M | n/m | 2015-04-15, From 2010-10-01 |
| 2010-09-30 | -$1.89M | n/a | 2011-12-28, From 2009-10-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$7.15M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$10.45M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$12.61M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.29M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$338.5K | n/m |
| America Great Health (AAGH) | 2025-06-30 | -$382.9K | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.95M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$13.28M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$42.59M | n/m |
Compare ABVC, HIND, ALLR, PVCT side by side · Screen every company in Pharmaceutical Preparations ↗